Tag: Competitive Analysis And Report

  • Global Gastrointestinal Therapeutics Industry Trends: Where the Market Is Headed by 2029

    Global Gastrointestinal Therapeutics Industry Trends: Where the Market Is Headed by 2029

    Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

    How Is The Gastrointestinal Therapeutics Market Size Likely To Evolve From 2025 Through 2034?

    The gastrointestinal therapeutics market has demonstrated substantial growth in recent times. This market is projected to expand from $39.99 billion in 2024 to reach $42.30 billion by 2025, exhibiting a compound annual growth rate (CAGR) of 5.8%. Historically, this expansion has been driven by factors such as increased government spending on healthcare, improved rates of early diagnosis, a surge in gut health awareness initiatives, a rise in digestive disorders linked to lifestyle, and the adoption of more multidisciplinary treatment methods.

    The gastrointestinal therapeutics market size is anticipated to experience substantial expansion in the coming years, with projections indicating it will reach $52.41 billion by 2029, growing at a compound annual growth rate (CAGR) of 5.5%. This growth throughout the forecast period is primarily driven by factors such as an escalating demand for biologics and targeted therapies, the increasing adoption of personalized medicine, a rising patient preference for combination therapies, an intensified focus on microbiome-targeted therapeutics, and the growing incidence of antibiotic-associated gastrointestinal complications. Significant trends expected during this period include the integration of advanced technology into endoscopic devices, the development of microbiome-based therapies, the incorporation of digital health and remote monitoring solutions, the utilization of multi-omics data in therapy development, and ongoing innovations in acid suppression treatments.

    Unlock Your Free Sample Report for Exclusive Market Data:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=25768&type=smp

    Which Major Market Drivers Are Shaping The Future Of The Gastrointestinal Therapeutics Market?

    The increasing incidence of inflammatory bowel diseases is projected to stimulate the growth of the gastrointestinal therapeutics market moving forward. Inflammatory bowel disease (IBD) is a long-term condition characterized by inflammation of the digestive tract, primarily involving Crohn’s disease and ulcerative colitis. The rise in inflammatory bowel diseases is attributed to genetic susceptibility, which causes an abnormal immune response to gut microbes. Gastrointestinal therapeutics aid in the management and treatment of bowel diseases by targeting underlying inflammation, regulating digestive functions, and alleviating associated symptoms to enhance patient outcomes. For instance, in December 2023, according to the IBD Registry, a UK-based non-profit organization, more than 5,300 individuals with inflammatory bowel diseases (IBD) were registered in 2023, indicating an increase of over 3,000 members from 2022. Consequently, the escalating occurrence of inflammatory bowel diseases is propelling the expansion of the gastrointestinal therapeutics market.

    What Are The Primary Types Of Segments Analyzed In The Gastrointestinal Therapeutics Market?

    The gastrointestinal therapeutics market covered in this report is segmented –

    1) By Product: Over-The-Counter Gastrointestinal Therapeutics, Prescription-Based Gastrointestinal Therapeutics

    2) By Route Of Administration: Oral, Intravenous, Other Routes Of Administration

    3) By Application: Inflammatory Bowel Disease, Gastroesophageal Reflux Disease, Peptic Ulcer Disease, Irritable Bowel Syndrome, Other Applications

    4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

    5) By End-User: Hospitals, Clinics, Ambulatory Surgical Centers, Diagnostic Laboratories, Other End-Users

    Subsegments:

    1) By Over-The-Counter Gastrointestinal Therapeutics: Antacids, Laxatives, Anti-Diarrheal Agents, Digestive Enzymes, Probiotics, H2-Receptor Antagonists, Simethicone Products

    2) By Prescription-Based Gastrointestinal Therapeutics: Proton Pump Inhibitors, Antibiotics For H. pylori, Aminosalicylates, Biologics, Corticosteroids, Immunosuppressants, Antiemetics

    How Are Emerging Market Trends Shaping The Gastrointestinal Therapeutics Industry Landscape?

    Leading companies in the gastrointestinal therapeutics market are prioritizing the creation of innovative therapies, such as sustained-release (SR) fixed-dose combination capsules, to enhance patient adherence and improve treatment efficacy. These sustained-release (SR) fixed-dose combination capsules are oral medications engineered to progressively release multiple active ingredients over time, thus maintaining consistent drug levels and minimizing dosing frequency. For example, in June 2024, Akums Drugs and Pharmaceuticals Limited, an India-based pharmaceutical preparation manufacturing company, introduced rabeprazole + levosulpiride SR capsules for managing gastrointestinal disorders in India. This formulation unites rabeprazole, a proton pump inhibitor that reduces stomach acid, with levosulpiride, a prokinetic agent that boosts gut motility. Together, they provide effective relief from symptoms including heartburn, acid reflux, bloating, and indigestion. This combination is broadly prescribed for the treatment of gastroesophageal reflux disease, peptic ulcers, and other related gastrointestinal (GI) conditions.

    Which Leading Players Are Enhancing Their Gastrointestinal Therapeutics Market Presence Worldwide?

    Major companies operating in the gastrointestinal therapeutics market are Abbott Laboratories, Novartis AG, Takeda Pharmaceutical Company Limited., Boehringer Ingelheim International GmbH, Otsuka Holdings Co. Ltd., Daiichi Sankyo Company Limited., Bausch Health Companies Inc, Olympus Corporation, UCB S.A., Eisai Co. Ltd., Aurobindo Pharma Limited., Dr. Reddy’s Laboratories Limited., Ironwood Pharmaceuticals Inc, Salix Pharmaceuticals Ltd., Ferring Pharmaceuticals A/S, Jubilant Pharma Limited., Sebela Pharmaceuticals Inc, Cosmo Pharmaceuticals N.V., Tillotts Pharma AG, Mitsubishi Tanabe Pharma Corporation

    Download The Full Report For Exclusive Market Findings:

    https://www.thebusinessresearchcompany.com/report/gastrointestinal-therapeutics-global-market-report

    Which Regional Markets Are Contributing Most To The Gastrointestinal Therapeutics Industry Expansion?

    North America was the largest region in the gastrointestinal therapeutics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gastrointestinal therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Request A Customized Version Of The Gastrointestinal Therapeutics Market Report:

    https://www.thebusinessresearchcompany.com/customise?id=25768&type=smp

    Browse Through More Reports Similar to the Global Gastrointestinal Therapeutics Market 2025, By The Business Research Company

    Gastrointestinal Drugs Global Market 2025

    https://www.thebusinessresearchcompany.com/report/gastrointestinal-drugs-global-market

    Gastroparesis Drugs Global Market Report 2025

    https://www.thebusinessresearchcompany.com/report/gastroparesis-drugs-global-market-report

    Digestive And Intestinal Remedies Global Market Report 2025

    https://www.thebusinessresearchcompany.com/report/digestive-and-intestinal-remedies-global-market-report

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 7882 955267 & +91 8897263534

    Europe +44 7882 955267

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Global Neglected Tropical Disease Treatment Market Trends and Growth Analysis 2025–2029

    Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

    By How Much Is The Neglected Tropical Disease Treatment Market Expected To Expand Between 2025 And 2029?

    The neglected tropical disease treatment market size has shown strong growth in recent years. It is forecast to grow from $3.36 billion in 2024 to $3.57 billion in 2025, achieving a compound annual growth rate (CAGR) of 6.3%. This historical growth can be attributed to an intensified government focus on disease elimination programs, expanding public-private partnerships for drug donations, increased pharmaceutical contributions by global drug manufacturers, a rise in research dedicated to low-cost antiparasitic treatments, and escalating investments in vaccine and diagnostic development.

    The neglected tropical disease treatment market is anticipated to experience robust expansion over the next few years. Its value is projected to reach $4.52 billion by 2029, growing at a compound annual growth rate (CAGR) of 6.1%. This expansion during the forecast period is attributable to the increasing deployment of digital tools for disease surveillance, an expanding array of new treatments and vaccines in development, intensified efforts to combat antimicrobial resistance, heightened cross-border collaboration for disease elimination, and the escalating spread of diseases driven by climate change. Key trends foreseen in this period include the establishment of localized treatment protocols, the creation of low-cost vaccine platforms, integration into primary healthcare systems, the unification of disease surveillance networks, and innovation in vector control solutions.

    Unlock Your Free Sample Report for Exclusive Market Data:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=24616&type=smp

    What Are The Main Drivers Boosting The Neglected Tropical Disease Treatment Industry’s Expansion?

    The increasing occurrence of infectious diseases is projected to drive the expansion of the neglected tropical disease treatment market in the future. Infectious diseases are illnesses caused by detrimental microorganisms such as bacteria, viruses, fungi, or parasites, capable of spreading directly or indirectly from one person to another. This growing prevalence of infectious diseases is attributable to increased travel, which facilitates the rapid spread of pathogens across international borders. Neglected tropical disease treatment assists with infectious diseases by delivering targeted therapies that manage and eliminate the spread of these conditions. These treatments enhance public health outcomes, especially in vulnerable communities, by lessening the disease burden and preventing long-term disabilities. For instance, in February 2024, the UK Health Security Agency, a UK-based government agency, reported that tuberculosis cases in England climbed to 4,850 in 2023, representing a 10.7% increase from 4,380 cases in 2022. Consequently, the rising prevalence of infectious diseases is fueling the growth of the neglected tropical disease treatment market.

    What Are The Leading Segments Analyzed In The Neglected Tropical Disease Treatment Market?

    The neglected tropical disease treatment market covered in this report is segmented –

    1) By Drug Class: Anti-Parasite, Antifungal, Antibiotics, Other Drugs Class

    2) By Disease Type: Leishmaniasis, Schistosomiasis, Lymphatic Filariasis, Chagas Disease, African Trypanosomiasis, Other Disease Types

    3) By Route of Administration: Oral, Parenteral

    4) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy

    5) By End User: Hospital, Specialty Clinics, Homecare Settings, Other End Users

    Subsegments:

    1) By Anti-Parasite: Anthelmintics, Antiprotozoals, Antimalarials, Ectoparasiticides

    2) By Antifungal: Azoles, Polyenes, Allylamines, Echinocandins

    3) By Antibiotics: Tetracyclines, Macrolides, Rifamycins, Sulfonamides

    4) By Other Drug Classes: Antivirals, Corticosteroids, Combination Therapies, Supportive Treatments

    Which Trends Are Impacting The Neglected Tropical Disease Treatment Market?

    Leading companies active in the neglected tropical disease treatment market are concentrating on strategic investments to bolster research and development, expand worldwide access, and refine innovative therapies. These strategic financial outlays are instrumental in driving the expansion of the neglected tropical disease treatment market by providing funds for advanced research, encouraging collaborations, and speeding up the creation of affordable and effective treatments for underserved communities. For example, in June 2022, Novartis AG, a pharmaceutical corporation based in Switzerland, invested $250 million towards the fight against neglected tropical diseases (NTDs) and malaria. This specific investment aims to improve the availability of treatments in low-income regions and supports the development of novel therapies for neglected tropical diseases.

    Which Global Market Leaders Are Shaping The Future Of The Neglected Tropical Disease Treatment Sector?

    Major companies operating in the neglected tropical disease treatment market are Pfizer Inc., Johnson And Johnson, Merck And Co. Inc., AbbVie Inc., Bayer AG, Novartis AG, Sanofi S.A., AstraZeneca PLC, Abbott Laboratories, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Astellas Pharma Inc., Eisai Co. Ltd., Shionogi And Co. Ltd., Dr. Reddy`s Laboratories Ltd, Cipla Ltd., Eiken Chemical Company Ltd, LifeArc, Atomwise Inc., Medicines Development for Global Health Ltd.

    Download The Full Report For Exclusive Market Findings:

    https://www.thebusinessresearchcompany.com/report/neglected-tropical-disease-treatment-global-market-report

    What Are The Regional Market Dynamics Impacting The Neglected Tropical Disease Treatment Industry?

    Asia-Pacific was the largest region in the neglected tropical disease treatment market in 2024. The regions covered in the neglected tropical disease treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Request A Customized Version Of The Neglected Tropical Disease Treatment Market Report:

    https://www.thebusinessresearchcompany.com/customise?id=24616&type=smp

    Browse Through More Reports Similar to the Global Neglected Tropical Disease Treatment Market 2025, By The Business Research Company

    Rare Diseases Treatment Global Market Report 2025

    https://www.thebusinessresearchcompany.com/report/rare-diseases-treatment-global-market-report

    Malaria Treatment Global Market Report 2025

    https://www.thebusinessresearchcompany.com/report/malaria-treatment-global-market-report

    Infectious Disease Therapeutics Global Market Report 2025

    https://www.thebusinessresearchcompany.com/report/infectious-disease-therapeutics-global-market-report

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 7882 955267 & +91 8897263534

    Europe +44 7882 955267

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • What Key Growth Drivers Are Shaping The Dental 3D Printing Devices Market Forecast Toward $11.57 Billion?

    What Key Growth Drivers Are Shaping The Dental 3D Printing Devices Market Forecast Toward $11.57 Billion?

    Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.

    How Big Is The Dental 3D Printing Devices Market Today And What Is Its Future Size?

    The market size for dental 3D printing devices has seen a swift ascent in recent years. It is anticipated to increase from $5.42 billion in 2024 to $6.33 billion in 2025 at a compound annual growth rate (CAGR) of 16.7%. The historical growth can be credited to the growing accessibility of biocompatible printing materials, escalating investment in dental healthcare infrastructure, a rising count of dental clinics and labs, a marked shift towards chairside dental solutions, and an increasing predilection for patient-specific dental devices.

    The market size for 3D printing devices in dentistry is expected to witness significant expansion in the coming years. The market is projected to reach $11.57 billion by 2029, with a compound annual growth rate (CAGR) of 16.3%. This projected growth in the forecast period can be linked with the rising prevalence of dental diseases, increasing demand for aesthetic dentistry, a growing elderly population, the increasing adoption of digital dentistry methodologies, and escalating consciousness about oral wellbeing. Notable trends anticipated during the prediction period encompass advancements in 3D printing technologies, progress in biocompatible printing materials, technological improvement in resin-based printing, advancements in multi-material printing systems, and innovation in hot lithography technology.

    Get A Free Sample Of The Report:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=25735&type=smp

    Which Demand Drivers Are Strengthening The Dental 3D Printing Devices Market?

    The anticipated increase in dental diseases is projected to drive the progression of the dental 3D printing devices market. Dental diseases comprise conditions that negatively impact the wellbeing, function, or anatomy of the teeth and associated oral tissues. These escalating conditions are primarily attributed to unhealthy diet habits, particularly high sugar and acid consumption that cause tooth caries and gum infections. The role of dental 3D printing devices is pivotal in addressing dental diseases as they allow for swift, accurate, and cost-efficient creation of tailored dental resolutions such as crowns, bridges, aligners, dentures, and surgical guides, enhancing treatment precision and patient results. For example, a report by the American Cancer Society in January 2024 predicted an estimated diagnosis of oral or oropharyngeal cancer in 58,450 US adults, including 41,510 men and 16,940 women, in 2024, as opposed to 54,000 adults in 2022. Consequently, the increasing occurrences of dental diseases are fostering the expansion of the dental 3D printing devices market.

    Which Segment Accounts For The Largest Share In The Dental 3D Printing Devices Market?

    The dental 3d printing devices market covered in this report is segmented –

    1) By Device Type: Desktop 3D Printers, Industrial 3D Printers, Dental Specific 3D Printers

    2) By Technology Type: Stereolithography (SLA), Digital Light Processing (DLP), Selective Laser Sintering (SLS), Material Jetting

    3) By Material Type: Resins, Biocompatible Materials, Thermoplastics, Wax

    4) By Application Area: Orthodontics, Prosthodontics, Implantology, Maxillofacial Surgery, Custom Dental Devices

    5) By End-User: Dental Laboratories, Dental Clinics, Educational Institutions, Research Organizations

    Subsegments:

    1) By Desktop 3D Printers: Resin-Based Desktop Printers, Fused Deposition Modeling (FDM) Desktop Printers, Multi-Material Desktop Printers

    2) By Industrial 3D Printers: Selective Laser Sintering (SLS) Industrial Printers, Multi-Jet Fusion (MJF) Printers, Binder Jetting Printers, Polyjet Printers

    3) By Dental Specific 3D Printers: Crown And Bridge Printers, Denture Printers, Orthodontic Appliance Printers, Surgical Guide Printers

    Which Long-Term Trends Will Play A Crucial Role In The Dental 3D Printing Devices Market?

    Leading firms in the dental 3D printing devices market are putting efforts into the development of cutting-edge technologies such as 3D-printed dentures. The goal is to increase accuracy in treatment, decrease processing times, and bolster patient-specific customization. The term 3D-printed dentures pertains to dental prosthetics that are designed digitally and manufactured using 3D printing technology, which allows for accurate, customizable, and efficient replacement of lost teeth. As an illustration, 3D Systems Corporation, an American computer manufacturing company, unveiled the industry’s inaugural multi-material, jetted, monolithic dentures in February 2024. This technology merges custom materials for teeth and gums into a single component, resulting in enhanced durability, resistance to breakage, and natural-looking aesthetics, whilst substantially cutting down production time and labor for dental labs. The outcome of this innovation is quicker, more comfortable, and longer-lasting dentures for patients, resulting in improved clinical results and patient satisfaction.

    Which Companies Hold A Competitive Edge In The 48 Market?

    Major companies operating in the dental 3d printing devices market are Renishaw, Stratasys Ltd., 3D Systems Corporation, Roland DG Corporation, Formlabs Inc., Materialise NV, Desktop Metal Inc., Carbon Inc., EnvisionTEC GmbH, SprintRay Inc., Prodways Group SA, UnionTech, Structo Pte. Ltd., Zortrax S.A., Kulzer GmbH, BEGO GmbH & Co. KG., Sisma S.p.A., Asiga Pty Ltd., Rapid Shape GmbH, Raise3D Technologies Inc.

    Access The Complete Report Here:

    https://www.thebusinessresearchcompany.com/report/dental-3d-printing-devices-global-market-report

    Which Region Is Forecasted To Lead The Dental 3D Printing Devices Market In The Coming Years?

    North America was the largest region in the dental 3D printing devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the dental 3d printing devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Customize Your Report Here:

    https://www.thebusinessresearchcompany.com/customise?id=25735&type=smp

    Browse Through More Reports Similar to the Global Dental 3D Printing Devices Market 2025, By The Business Research Company

    Dental 3D Scanners Global Market Report 2025

    https://www.thebusinessresearchcompany.com/report/dental-3d-scanners-global-market-report

    3D Printing In Healthcare Global Market Report 2025

    https://www.thebusinessresearchcompany.com/report/3d-printing-in-healthcare-global-market-report

    3D Printing Materials Global Market Report 2025

    https://www.thebusinessresearchcompany.com/report/3d-printing-materials-global-market-report

    About The Business Research Company:

    With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 7882 955267 & +91 8897263534

    Europe +44 7882 955267

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Global Continence Care Market Forecast 2029: Size, Share, and Competitive Landscape

    Global Continence Care Market Forecast 2029: Size, Share, and Competitive Landscape

    Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.

    How Is The Continence Care Market Expected To Grow In Terms Of Size?

    There has been a notable expansion in the size of the continence care market in the past few years. Its size is projected to surge from $15.13 billion in 2024 to an estimated $16.15 billion in 2025, which represents a compound annual growth rate (CAGR) of 6.7%. Numerous factors have contributed to this growth in the past, including an expanding elderly population, heightened awareness about personal sanitation, escalating figures of chronic illnesses, mobility restrictions among the aged population, and a rise in the rates of institutional care admissions.

    The market size for continence care is predicted to witness considerable growth in the upcoming years, escalating to $20.78 billion in 2029 with a 6.5% compound annual growth rate (CAGR). The increase in the projected timeline is due to the surging need for home healthcare, the broadening of e-commerce platforms, growing healthcare expenses, bettering reimbursement policies, and an upswing in urologic disorders. Key trends during the forecast period encompass technological progress in absorbent materials, breakthroughs in smart continence devices, evolvement in biodegradable products, ongoing research and innovation in skin-friendly materials, and the incorporation of wearable sensors.

    Get A Free Sample Of The Report:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=25728&type=smp

    What Market Forces Are Contributing To The Growth Of The Continence Care Market?

    The continence care market is poised for growth, driven by an uptick in urological disorders. These disorders, which can affect the urinary tract system including the kidneys, bladder, and urethra, are increasingly prevalent, largely due to an aging population. Older adults often suffer from urinary tract problems because of reduced muscle tone and other changes associated with aging. Continence care offers a solution to manage symptoms and enhance the comfort of those suffering from urological conditions. This care includes vital products that promote urinary control, hygiene, and an improved quality of life, particularly for those with chronic bladder problems or urinary issues related to aging. As an example, in November 2024, the American Urological Association revealed that over 33 million Americans were dealing with overactive bladder symptoms. In addition, interstitial cystitis or bladder pain syndrome was a reality for an estimated 1 to 4 million men and roughly 3 to 8 million women. Therefore, the rising occurrence of urological disorders is fueling growth in the continence care market.

    How Is The Continence Care Market Segmented Across Key Categories?

    The continence care market covered in this report is segmented –

    1) By Product: Urinary Catheter, Non-Implanting Electric Stimulation Devices, Protective Garments, Urine Bag, Bowel Management Products, Other Products

    2) By Material Type: Cotton, Polymer, Nonwoven Fabrics, Foam

    3) By Application: Diabetes, Strokes, Benign Prostatic Hyperplasia, Alzheimer, Cerebral Palsy, Parkinson, Prostate Cancer, Spinal Cord Injury, Bladder Cancer, Other Applications

    4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Stores, Medical Supply Stores

    5) By End User: Hospitals, Home Care Settings, Nursing Homes, Clinics

    Subsegments:

    1) By Urinary Catheter: Intermittent Catheters, Indwelling (Foley) Catheters, External (Condom) Catheters, Suprapubic Catheters, Catheter Maintenance Products

    2) By Non-Implanting Electric Stimulation Devices: Pelvic Floor Stimulators, Transcutaneous Electrical Nerve Stimulation (TENS) Devices For Bladder Control, External Tibial Nerve Stimulation Devices

    3) By Protective Garments: Adult Diapers, Protective Underwear, Pads And Liners, Male Guards, Belted Shields

    4) By Urine Bag: Leg Urine Bags, Bedside Urine Bags, Pediatric Urine Bags, Night Drainage Bags, Urine Bag Accessories

    5) By Bowel Management Products: Rectal Catheters, Stool Collection Bags, Irrigation Systems, Anal Plugs, Bowel Stimulation Devices

    6) By Other Products: Absorbent Sheets, Skin Care Products For Incontinence, Odor Control Products, Deodorizing Tablets

    What Key Trends Are Driving Growth In The Continence Care Market?

    Leading companies in the continence care market are increasingly focusing on the creation of innovative solutions such as digital health technologies to aid real-time urinary tracking, manage hydration, and offer personalized continence care. Digital health solutions point towards the incorporation of digital technologies including mobile apps, connected devices and software to boost health management, optimize patient outcomes and amplify care delivery efficiency. They function by facilitating real-time tracking, providing personalized health analyses, enabling remote monitoring, and fostering improved dialogue between patients and their healthcare providers. For example, in August 2024, UK-based medical product and technology firm, Convatec Group Plc introduced the me+ Companion app. This digital health remedy was developed chiefly to support intermittent catheter users and healthcare professionals through real-time urinary tracking, setting hydration targets, recording leaks, and producing customized summary reports for enhanced continence care control. The app provides a convenient platform for users to record their liquid consumption and urine production via their mobile devices, thereby gaining a better understanding of their situation to make educated decisions. It also boosts effective communication between patients and their care teams by permitting users to share downloadable and printable reports.

    Who Are The Major Stakeholders Operating In The Continence Care Market?

    Major companies operating in the continence care market are Cardinal Health Inc., 3M Healthcare, Medtronic plc, Kimberly-Clark Corporation, Unicharm Corporation, Coloplast A/S, Paul Hartmann AG, Convatec Group PLC, Ontex International N.V., Drylock Technologies, First Quality Enterprises Inc., Hollister Incorporated, ABENA A/S, Lohmann & Rauscher GmbH & Co. KG, B. Braun Melsungen AG, Principle Business Enterprises Inc., Premiere Care Industries Inc., Santex S.p.A., Pioneer Hygiene Industries, TZMO SA.

    Access The Complete Report Here:

    https://www.thebusinessresearchcompany.com/report/continence-care-global-market-report

    How Do Regional Dynamics Influence The Continence Care Market Performance?

    North America was the largest region in the continence care market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the continence care market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Customize Your Report Here:

    https://www.thebusinessresearchcompany.com/customise?id=25728&type=smp

    Browse Through More Reports Similar to the Global Continence Care Market 2025, By The Business Research Company

    Hospice Care Global Market Report 2025

    https://www.thebusinessresearchcompany.com/report/hospice-care-global-market-report

    Personal Care Services Global Market Report 2025

    https://www.thebusinessresearchcompany.com/report/personal-care-services-market

    Personal Care Services Global Market Report 2025

    https://www.thebusinessresearchcompany.com/report/personal-care-services-market

    About The Business Research Company:

    With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 7882 955267 & +91 8897263534

    Europe +44 7882 955267

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Global Connective Tissue Disease Treatment Market Trends 2025–2029: Regional Outlook and Sizing Analysis

    Global Connective Tissue Disease Treatment Market Trends 2025–2029: Regional Outlook and Sizing Analysis

    Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.

    How Much Will The Connective Tissue Disease Treatment Market Be Worth By 2029?

    The market size for the treatment of connective tissue disease has experienced substantial growth in the last few years. It is predicted to expand from $23.08 billion in 2024 to $24.55 billion in 2025, with a compound annual growth rate (CAGR) of 6.3%. The growth observed in the historical period can be credited to the escalating prevalence of autoimmune disorders, heightened knowledge about early diagnosis, the enhancement of healthcare facilities in developing areas, increased use of biologics, and broadening insurance coverage for chronic disease management.

    Over the next few years, the market size for connective tissue disease treatment is expected to witness robust growth, reaching a valuation of $31.11 billion in 2029 at a compound annual growth rate (CAGR) of 6.1%. This substantial growth in the projected period can be linked to numerous factors, including a growing aging population, increased R&D funding by pharmaceutical entities, a surge in demand for tailor-made medicine, an expanding pipeline for target-specific therapies, and a heightened focus on patient-oriented care models. The forecast period is set to see certain major trends such as advancements in monoclonal antibody therapies, the incorporation of telemedicine for disease tracking, a shift towards biologics and biosimilars, the formulation of drugs targeting multiple conditions, along with an increased partnership between academic and clinical research institutions.

    Get A Free Sample Of The Report:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=25726&type=smp

    Which Key Factors Are Fueling Growth In The Connective Tissue Disease Treatment Market?

    The escalation in the prevalence of autoimmune diseases is projected to be a major catalyst for the expansion of the connective tissue disease treatment market in the future. Autoimmune diseases are conditions where the body’s immune system erroneously attacks its healthy tissues and organs. This surge in autoimmune diseases is primarily attributed to a blend of genetic susceptibility, which puts certain individuals at a higher risk of immune system breakdown, and environmental factors such as infections, diet, stress, and exposure to toxins, which can instigate or exacerbate these ailments. Connective tissue disease treatment aids in managing autoimmune diseases by addressing the root cause of the immune system imbalance leading to inflammation and tissue damage. This in turn helps in easing symptoms, halting the pace of the disease, and bettering the overall quality of life for those suffering from lupus, rheumatoid arthritis, and scleroderma, among others. For example, as stated by Versorgungsatlas.de, a German online platform that provides healthcare data, in November 2024, 6,304,340 out of 73,241,305 insured individuals were identified with at least one autoimmune disease in 2022, resulting in a gross prevalence rate of 8.61%. Therefore, the surging occurrence of autoimmune diseases is stimulating the growth of the connective tissue disease treatment market.

    Which Segmentation Factors Are Critical In The Connective Tissue Disease Treatment Market Analysis?

    The connective tissue disease treatment market covered in this report is segmented –

    1) By Drug Class: Anti-Inammatory Drugs, Immunosuppressants, Biologics And Targeted Therapy, Disease-Modifying Anti-Rheumatic Drugs (DMARDs), Other Drug Classes

    2) By Disease Type: Systemic Lupus Erythematosus (SLE), Rheumatoid Arthritis (RA), Scleroderma, Dermatomyositis, Mixed Connective Tissue Disease (MCTD), Polymyositis, Sjögren’s Syndrome, Vasculitis, Antiphospholipid Syndrome (APS)

    3) By Route Of Administration: Oral, Injectable, Topical

    4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

    5) By End-User: Hospitals, Clinics, Homecare Settings

    Subsegments:

    1) By Anti-Inflammatory Drugs: Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), Systemic Corticosteroids

    2) By Immunosuppressants: Calcineurin Inhibitors, Mammalian Target Of Rapamycin (mTOR) Inhibitors, Antimetabolites, Alkylating Agents

    3) By Biologics And Targeted Therapy: Tumor Necrosis Factor (TNF) Inhibitors, Interleukin-6 (IL-6) Inhibitors, B-Cell Inhibitors, T-Cell Co-Stimulation Modulators, Janus Kinase (JAK) Inhibitors

    4) By Disease-Modifying Anti-Rheumatic Drugs (DMARDs): Conventional Synthetic Disease-Modifying Anti-Rheumatic Drugs (DMARDs), Biologic Disease-Modifying Anti-Rheumatic Drugs (DMARDs), Targeted Synthetic Disease-Modifying Anti-Rheumatic Drugs (DMARDs)

    5) By Other Drug Classes: Analgesics, Antimalarial Drugs, Antibiotics, Monoclonal Antibodies

    What Are The Dominant Trends Currently Seen In The Connective Tissue Disease Treatment Market?

    Leading entities operating in the connective tissue disease treatment market are intensifying efforts to conduct clinical experiments with a view to concoct ground-breaking treatments such as allogeneic CAR-NK cell therapy. This initiative is aimed at enhancing efficacy and filling the gap in dealing with autoimmune disorders. Allogeneic CAR-NK cell therapy, a treatment that utilizes natural killer (NK) cells, obtained from healthy donors and genetically modified via a chimeric antigen receptor (CAR), is used to identify and eliminate cells causing disease. This therapy boosts the immune system’s capacity to wipe out detrimental B-cells implicated in autoimmune disorders, offering a possibly safer and more feasible option compared to conventional cell therapies. Notably, in July 2024, Nkarta Inc., a clinical-stage biotechnology firm from the US, initiated the Ntrust-1 clinical trial to measure the effectiveness of NKX019, a novel allogeneic CAR-NK cell therapy, for lupus nephritis treatment, and garnered FDA approval to commence a distinct trial (Ntrust-2) for systemic sclerosis, idiopathic inflammatory myopathy, and ANCA-associated vasculitis. The main target is to address considerable unmet requirements in autoimmune disorders by escalating safety, accessibility, and efficacy of cell-centric therapies through engineered NK cells that selectively pinpoint CD19-expressing B-cells.

    Which Players Are Shaping The Competitive Landscape Of The Connective Tissue Disease Treatment Market?

    Major companies operating in the connective tissue disease treatment market are Pfizer Inc., F. Hoffmann-La Roche AG, AbbVie Inc., Sanofi S.A., Bristol Myers Squibb Company, AstraZeneca PLC, Novartis AG, GlaxoSmithKline (GSK) PLC, Eli Lilly and Company, Amgen Inc., Biogen Inc., Vertex Pharmaceuticals, UCB S.A., Hikma Pharmaceuticals PLC, Innovent Biologics Inc., RemeGen Co. Ltd, Kymera Therapeutics, Adicet Bio, Equillium Inc., Stem Cell Care India.

    Access The Complete Report Here:

    https://www.thebusinessresearchcompany.com/report/connective-tissue-disease-treatment-global-market-report

    Which Region Is Likely To Register The Fastest Growth In The Connective Tissue Disease Treatment Market?

    North America was the largest region in the connective tissue disease treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the connective tissue disease treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Customize Your Report Here:

    https://www.thebusinessresearchcompany.com/customise?id=25726&type=smp

    Browse Through More Reports Similar to the Global Connective Tissue Disease Treatment Market 2025, By The Business Research Company

    Crohns Disease Treatment Global Market Report 2025

    https://www.thebusinessresearchcompany.com/report/crohns-disease-treatment-global-market-report

    Orthopedic Soft Tissue Repair Global Market Report 2025

    https://www.thebusinessresearchcompany.com/report/orthopedic-soft-tissue-repair-global-market-report

    Graft Versus Host Disease Gvhd Treatment Global Market Report 2025

    https://www.thebusinessresearchcompany.com/report/graft-versus-host-disease-gvhd-treatment-global-market-report

    About The Business Research Company:

    With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 7882 955267 & +91 8897263534

    Europe +44 7882 955267

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • What Is The Predicted Revenue Outlook For The Global Gastrointestinal Therapeutics Market To Surpass $52.41 Billion?

    Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.

    What Are The Market Size Estimates For The Gastrointestinal Therapeutics Market?

    There has been robust growth in the size of the gastrointestinal therapeutics market in the last few years. The market is projected to swell from $39.99 billion in 2024 to $42.30 billion in 2025, boasting a compound annual growth rate (CAGR) of 5.8%. Factors contributing to this growth during the historical period include a spike in government spending on healthcare, improved rates of early diagnosis, enhanced gut health awareness programs, a surge in digestive disorders tied to lifestyle, and the rise of multidisciplinary treatment strategies.

    Strong growth is anticipated in the gastrointestinal therapeutics market size over the coming years, with its value predicted to reach $52.41 billion in 2029, achieving a compound annual growth rate (CAGR) of 5.5%. The expansion during the forecast period can be ascribed to heightened demand for biologics and targeted therapies, a rising inclination towards personalised medicine, increased patient interest in combination therapies, a growing focus on therapeutics targeting the microbiome, and an increase in gastrointestinal complications associated with antibiotics. Major trends to watch during the forecast period include the integration of technology in endoscopic devices, the development of therapies based on the microbiome, the integration of digital health and remote monitoring, the utilization of multi-omics data in therapy development, and innovations in acid suppression therapies.

    Get A Free Sample Of The Report:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=25768&type=smp

    Which Industry Forces Are Driving The Gastrointestinal Therapeutics Market Forward?

    The escalation in inflammatory bowel diseases is predicted to boost the expansion of the gastrointestinal therapeutics market in the future. Inflammatory bowel disease (IBD) is a long-lasting disease causing inflammation in the digestive tract, predominantly including Crohn’s disease and ulcerative colitis. The escalation in inflammatory bowel diseases can be attributed to genetic susceptibility leading to an irregular immune response to gut microbes. Gastrointestinal therapeutics facilitates the management and treatment of bowel diseases by focusing on the underlying inflammation, adjusting digestive functions and easing related symptoms to enhance patient outcomes. For example, in December 2023, the UK-based IBD Registry, a non-profit organization, registered over 5,300 individuals with inflammatory bowel diseases (IBD), indicating an increase of over 3,000 members from 2022. Consequently, the escalation in inflammatory bowel diseases is propelling the expansion of the gastrointestinal therapeutics market.

    How Is The Gastrointestinal Therapeutics Market Organized By Different Segments?

    The gastrointestinal therapeutics market covered in this report is segmented –

    1) By Product: Over-The-Counter Gastrointestinal Therapeutics, Prescription-Based Gastrointestinal Therapeutics

    2) By Route Of Administration: Oral, Intravenous, Other Routes Of Administration

    3) By Application: Inflammatory Bowel Disease, Gastroesophageal Reflux Disease, Peptic Ulcer Disease, Irritable Bowel Syndrome, Other Applications

    4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

    5) By End-User: Hospitals, Clinics, Ambulatory Surgical Centers, Diagnostic Laboratories, Other End-Users

    Subsegments:

    1) By Over-The-Counter Gastrointestinal Therapeutics: Antacids, Laxatives, Anti-Diarrheal Agents, Digestive Enzymes, Probiotics, H2-Receptor Antagonists, Simethicone Products

    2) By Prescription-Based Gastrointestinal Therapeutics: Proton Pump Inhibitors, Antibiotics For H. pylori, Aminosalicylates, Biologics, Corticosteroids, Immunosuppressants, Antiemetics

    What Current And Upcoming Trends Are Shaping The Gastrointestinal Therapeutics Market?

    Focused on innovation, key players in the gastrointestinal therapeutics market are working towards improved patient adherence and overall efficiency of treatments by developing advanced therapies. This includes the use of sustained-release (SR) fixed-dose combination capsules. These oral medications slowly release a set of active ingredients over a period of time to establish consistent drug levels and help decrease the frequency of dosages. For example, Akums Drugs and Pharmaceuticals Limited, a pharmaceutical preparation manufacturing company based in India, unveiled their launch of rabeprazole + levosulpiride SR capsules for the treatment of gastrointestinal illnesses in June 2024. Rabeprazole, a proton pump inhibitor that minimizes stomach acid, is combined with levosulpiride, a prokinetic agent that boosts gut motility. The combination assists in alleviating symptoms including heartburn, acid reflux, bloating, and indigesticonsistently. It’s frequently recommended for managing diseases like gastroesophageal reflux, peptic ulcers, and other gastrointestinal (GI) conditions.

    Who Are The Primary Market Leaders In The Gastrointestinal Therapeutics Market?

    Major companies operating in the gastrointestinal therapeutics market are Abbott Laboratories, Novartis AG, Takeda Pharmaceutical Company Limited., Boehringer Ingelheim International GmbH, Otsuka Holdings Co. Ltd., Daiichi Sankyo Company Limited., Bausch Health Companies Inc, Olympus Corporation, UCB S.A., Eisai Co. Ltd., Aurobindo Pharma Limited., Dr. Reddy’s Laboratories Limited., Ironwood Pharmaceuticals Inc, Salix Pharmaceuticals Ltd., Ferring Pharmaceuticals A/S, Jubilant Pharma Limited., Sebela Pharmaceuticals Inc, Cosmo Pharmaceuticals N.V., Tillotts Pharma AG, Mitsubishi Tanabe Pharma Corporation

    Access The Complete Report Here:

    https://www.thebusinessresearchcompany.com/report/gastrointestinal-therapeutics-global-market-report

    How Do Regional Dynamics Influence The Gastrointestinal Therapeutics Market Performance?

    North America was the largest region in the gastrointestinal therapeutics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gastrointestinal therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Customize Your Report Here:

    https://www.thebusinessresearchcompany.com/customise?id=25768&type=smp

    Browse Through More Reports Similar to the Global Gastrointestinal Therapeutics Market 2025, By The Business Research Company

    Gastric Cancer Drugs Global Market Report 2025

    https://www.thebusinessresearchcompany.com/report/gastric-cancer-drugs-global-market-report

    Gastroesophageal Reflux Disease Therapeutics Global Market Report 2025

    https://www.thebusinessresearchcompany.com/report/gastroesophageal-reflux-disease-therapeutics-global-market-report

    Intestine Cancer Therapeutics Global Market Report 2025

    https://www.thebusinessresearchcompany.com/report/intestine-cancer-therapeutics-global-market-report

    About The Business Research Company:

    With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 7882 955267 & +91 8897263534

    Europe +44 7882 955267

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Neglected Tropical Disease Treatment Market Revenue Outlook: Strategic Insights and Forecast to 2029

    Neglected Tropical Disease Treatment Market Revenue Outlook: Strategic Insights and Forecast to 2029

    Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

    How Will the Neglected Tropical Disease Treatment Market Evolve in Terms of Growth and Size by 2029?

    The market for treating neglected tropical diseases has seen robust expansion in the past years. It is projected to increase from $3.36 billion in 2024 to $3.57 billion in 2025, with a compound annual growth rate (CAGR) of 6.3%. Contributing factors to this growth during the historical period include enhanced attention from governments towards disease eradication programs, a rise in public-private collaboration for medication contributions, an uptick in pharmaceutical donations by worldwide drug producers, amplified research into cost-effective antiparasitic therapies, and escalated investment in the development of vaccines and diagnostics.

    The market size for the treatment of neglected tropical diseases is predicted to significantly enlarge in the forthcoming years. Its value is expected to hit $4.52 billion in 2029, growing at a compound annual growth rate (CAGR) of 6.1%. This growth over the forecast period can be attributed to the increased use of digital tools for disease monitoring, a robust pipeline of new treatments and vaccines, mounting pressure to tackle antimicrobial resistance, enhanced cross-border cooperation for disease eradication, and the rising disease spread due to climate change. Key trends in this period are expected to be the development of localized treatment methods, the creation of cost-effective vaccine platforms, the merger with primary healthcare systems, the amalgamation of disease surveillance networks, and innovation in vector control solutions.

    Download The Free Sample Report Here:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=24616&type=smp

    What factors are expected to fuel Neglected Tropical Disease Treatment market growth in the coming years?

    The increasing occurrence of infectious diseases is anticipated to drive the expansion of the neglected tropical disease treatment market. Infectious diseases, caused by harmful microorganisms such as bacteria, viruses, fungi, or parasites, can transmit directly or indirectly between individuals. The upsurge in these diseases is attributed to the rise in travel, enabling the swift transmission of pathogens across international borders. Neglected tropical disease treatments play a significant role in managing infectious diseases by offering specialized therapies to control and eradicate the spread of diseases. These treatments enhance public health consequences, particularly in susceptible communities, by lowering the disease load and preventing prolonged disabilities. For example, the UK Health Security Agency, a UK government agency, reported in February 2024 that tuberculosis cases in England escalated to 4,850 in 2023, marking a growth of 10.7% from 4,380 cases in 2022. Consequently, the escalating occurrence of infectious diseases is contributing to the growth of the neglected tropical disease treatment market.

    What Are The Key Findings From The Segmentation Analysis Of The Neglected Tropical Disease Treatment Market?

    The neglected tropical disease treatment market covered in this report is segmented –

    1) By Drug Class: Anti-Parasite, Antifungal, Antibiotics, Other Drugs Class

    2) By Disease Type: Leishmaniasis, Schistosomiasis, Lymphatic Filariasis, Chagas Disease, African Trypanosomiasis, Other Disease Types

    3) By Route of Administration: Oral, Parenteral

    4) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy

    5) By End User: Hospital, Specialty Clinics, Homecare Settings, Other End Users

    Subsegments:

    1) By Anti-Parasite: Anthelmintics, Antiprotozoals, Antimalarials, Ectoparasiticides

    2) By Antifungal: Azoles, Polyenes, Allylamines, Echinocandins

    3) By Antibiotics: Tetracyclines, Macrolides, Rifamycins, Sulfonamides

    4) By Other Drug Classes: Antivirals, Corticosteroids, Combination Therapies, Supportive Treatments

    Which Trends Are Expected To Shape The Future Of The Neglected Tropical Disease Treatment Market?

    Companies in the forefront of neglected tropical disease treatment are centering their objectives around strategic capital infusion to boost R&D, increase global availability and enhance innovative treatment strategies. The neglected tropical disease treatment market is being advanced due to these strategic investments which fund research advancements, cultivate partnerships and expedite the creation of effective, affordable treatments for populations lacking adequate healthcare. For example, a Swiss pharmaceutical firm, Novartis AG, in June 2022, allocated a substantial amount of $250 million towards combating neglected tropical diseases (NTDs) and malaria. This allocation is intended to improve the accessibility of treatments in poorer regions and prop up the creation of novel treatments for neglected tropical diseases.

    What Are The Most Active Companies In The Neglected Tropical Disease Treatment Market Today?

    Major companies operating in the neglected tropical disease treatment market are Pfizer Inc., Johnson And Johnson, Merck And Co. Inc., AbbVie Inc., Bayer AG, Novartis AG, Sanofi S.A., AstraZeneca PLC, Abbott Laboratories, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Astellas Pharma Inc., Eisai Co. Ltd., Shionogi And Co. Ltd., Dr. Reddy`s Laboratories Ltd, Cipla Ltd., Eiken Chemical Company Ltd, LifeArc, Atomwise Inc., Medicines Development for Global Health Ltd.

    Get The Full Report Here:

    https://www.thebusinessresearchcompany.com/report/neglected-tropical-disease-treatment-global-market-report

    Which Regional Markets Are Attracting The Most Investment In Neglected Tropical Disease Treatment?

    Asia-Pacific was the largest region in the neglected tropical disease treatment market in 2024. The regions covered in the neglected tropical disease treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Request For A Customized Report:

    https://www.thebusinessresearchcompany.com/customise?id=24616&type=smp

    About The Business Research Company:

    With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 7882 955267 & +91 8897263534

    Europe +44 7882 955267

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Industry Trends Show Gastrointestinal Therapeutics Market Set to Expand at 5.5% CAGR Until 2029

    Industry Trends Show Gastrointestinal Therapeutics Market Set to Expand at 5.5% CAGR Until 2029

    Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

    Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

    What Is the Current and Projected Market Size of the Gastrointestinal Therapeutics Industry?

    In recent years, there has been a significant expansion of the gastrointestinal therapeutics market. The market, which stood at $39.99 billion in 2024, is projected to escalate to $42.30 billion in 2025, with a compound annual growth rate (CAGR) of 5.8%. Factors contributing to this increase during the historic period include heightened government spending on healthcare, improved rates of early diagnosis, an increase in awareness initiatives regarding gut health, a rise in lifestyle-based digestive ailments, and an augmented use of multidisciplinary approaches to treatment.

    Intense growth is projected for the gastrointestinal therapeutics market in the upcoming years, with expectancy of reaching $52.41 billion by 2029, reflecting a compound annual growth rate (CAGR) of 5.5%. The growth during this forecast period is primarily due to the increased demand for biologics and targeted treatments, the swell in the implementation of personalized medicine, a hike in patients’ inclination towards combination therapies, a rising focus on microbiome-specific treatments, and an increase in antibiotic-related gastrointestinal complications. The forecast period will witness various trends such as the use of technology in endoscopic devices, the creation of microbiome-oriented treatments, the confluence of digital health and remote monitoring, the utilization of multi-omics data in the advancement of therapies, and breakthroughs in acid suppression treatments.

    Download The Free Sample Report Here:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=25768&type=smp

    #Which Factors Are Currently Driving The Growth Of The Gastrointestinal Therapeutics Market?

    The escalating incidence of inflammatory bowel diseases is projected to accelerate the expansion of the gastrointestinal therapeutics market. Inflammatory bowel disease (IBD), a long-term ailment, triggers inflammation of the digestive tract and mainly consists of Crohn’s disease and ulcerative colitis. The escalation of these diseases is attributed to genetic risk, leading to an anomalous immune reaction to intestinal microbes. Gastrointestinal therapeutics aid in managing and treating bowel diseases by addressing the root inflammation, managing digestive functions, and easing related symptoms to enhance patient results. For instance, the IBD Registry, a UK non-profit organization, reported that over 5,300 individuals with inflammatory bowel diseases (IBD) were registered in December 2023, indicating an increase of more than 3,000 members from the previous year. Consequently, the escalating incidences of inflammatory bowel diseases are propelling the growth of the gastrointestinal therapeutics market.

    How Is The Global Gastrointestinal Therapeutics Market Structured In Terms Of Segments?

    The gastrointestinal therapeutics market covered in this report is segmented –

    1) By Product: Over-The-Counter Gastrointestinal Therapeutics, Prescription-Based Gastrointestinal Therapeutics

    2) By Route Of Administration: Oral, Intravenous, Other Routes Of Administration

    3) By Application: Inflammatory Bowel Disease, Gastroesophageal Reflux Disease, Peptic Ulcer Disease, Irritable Bowel Syndrome, Other Applications

    4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

    5) By End-User: Hospitals, Clinics, Ambulatory Surgical Centers, Diagnostic Laboratories, Other End-Users

    Subsegments:

    1) By Over-The-Counter Gastrointestinal Therapeutics: Antacids, Laxatives, Anti-Diarrheal Agents, Digestive Enzymes, Probiotics, H2-Receptor Antagonists, Simethicone Products

    2) By Prescription-Based Gastrointestinal Therapeutics: Proton Pump Inhibitors, Antibiotics For H. pylori, Aminosalicylates, Biologics, Corticosteroids, Immunosuppressants, Antiemetics

    What Trends Are Currently Influencing Growth In The Gastrointestinal Therapeutics Market?

    Top-tier firms in the gastrointestinal therapeutics market are concentrating their efforts on the creation of innovative treatments, such as sustained-release (SR) fixed-dose blend capsules. This new method aims to increase patient adherence and elevate the potency of treatments. The sustained-release (SR) fixed-dose blend capsules are oral treatments that methodically release numerous active components over a certain period. This method ensures steady drug levels and less frequent dosing. For example, Akums Drugs and Pharmaceuticals Limited, a pharmaceutical manufacturing corporation based in India, introduced rabeprazole + levosulpiride SR capsules in June 2024. These capsules are intended for the treatment of various gastrointestinal issues in India. The specific formula merges rabeprazole, a proton pump inhibitor that lowers stomach acid, and levosulpiride, a prokinetic agent that raises gut movement. Collectively, they provide effective relief from symptoms such as heartburn, acid reflux, bloating, and indigestion. This combination is commonly recommended for gastroesophageal reflux disease, peptic ulcers, and other similar gastrointestinal (GI) issues.

    Who Are The Main Participants Shaping The Gastrointestinal Therapeutics Market Landscape?

    Major companies operating in the gastrointestinal therapeutics market are Abbott Laboratories, Novartis AG, Takeda Pharmaceutical Company Limited., Boehringer Ingelheim International GmbH, Otsuka Holdings Co. Ltd., Daiichi Sankyo Company Limited., Bausch Health Companies Inc, Olympus Corporation, UCB S.A., Eisai Co. Ltd., Aurobindo Pharma Limited., Dr. Reddy’s Laboratories Limited., Ironwood Pharmaceuticals Inc, Salix Pharmaceuticals Ltd., Ferring Pharmaceuticals A/S, Jubilant Pharma Limited., Sebela Pharmaceuticals Inc, Cosmo Pharmaceuticals N.V., Tillotts Pharma AG, Mitsubishi Tanabe Pharma Corporation

    Get The Full Report Here:

    https://www.thebusinessresearchcompany.com/report/gastrointestinal-therapeutics-global-market-report

    Which Region Currently Holds The Largest Share In The Gastrointestinal Therapeutics Market?

    North America was the largest region in the gastrointestinal therapeutics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gastrointestinal therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Request For A Customized Report:

    https://www.thebusinessresearchcompany.com/customise?id=25768&type=smp

    About The Business Research Company:

    With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 7882 955267 & +91 8897263534

    Europe +44 7882 955267

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • 2025 Dental 3D Printing Devices Market Outlook: Opportunities, Growth Trends, and Strategic Analysis

    2025 Dental 3D Printing Devices Market Outlook: Opportunities, Growth Trends, and Strategic Analysis

    Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

    Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

    What Are the Latest Market Insights for the Dental 3D Printing Devices Industry?

    The market for dental 3D printing devices has experienced swift expansion in recent times. It’s projected that its size will increase from $5.42 billion in 2024 to $6.33 billion in 2025, with a compound annual growth rate (CAGR) of 16.7%. Factors contributing to its historic growth include the increased accessibility of biocompatible printing materials, enhanced investment in dental health infrastructure, a rise in dental clinics and laboratories, a shift towards chairside dental solutions, and a trend towards patient-specific dental equipment.

    In the following years, a significant expansion is anticipated in the dental 3D printing devices market. The market size is predicted to reach $11.57 billion in 2029, with a compound annual growth rate (CAGR) of 16.3%. Factors such as a boost in dental disorder cases, an increased demand for cosmetic dentistry, a rising elderly population, the growing utilization of digital dentistry procedures, and heightened awareness around oral health contribute to the growth during the forecast period. The forecast period will also witness major trends such as improvements in 3D printing technologies, progression in biocompatible printing materials, tech innovation in resin-based printing, enhancements in multi-material printing systems, and advancements in hot lithography technology.

    Download The Free Sample Report Here:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=25735&type=smp

    What Forces Are Driving The Growth Of The Dental 3D Printing Devices Industry?

    The increase in dental disorders is anticipated to spur the growth of the dental 3D printing devices market. Dental disorders, a range of conditions that affect the health, function, or structure of the teeth and surrounding oral tissues, are largely caused by poor dietary habits, particularly high sugar and acid intake that lead to tooth decay and gum disease. Dental 3D printing devices play a significant role in managing these disorders by facilitating quick, accurate, and cost-friendly production of personalized dental products such as crowns, bridges, aligners, dentures, and surgical guides, enhancing the precision of treatments and patient results. For example, a report by the American Cancer Society, a nonprofit cancer advocacy organization in the U.S, revealed that approximately 58,450 adults in the United States, consisting of 41,510 men and 16,940 women, are expected to be diagnosed with oral or oropharyngeal cancer in 2024, an increase from 54,000 adults in 2022. Thus, the escalating prevalence of dental disorders is fueling the growth of the dental 3D printing devices market.

    What Is The Overview Of Market Segmentation In The Dental 3D Printing Devices Industry?

    The dental 3d printing devices market covered in this report is segmented –

    1) By Device Type: Desktop 3D Printers, Industrial 3D Printers, Dental Specific 3D Printers

    2) By Technology Type: Stereolithography (SLA), Digital Light Processing (DLP), Selective Laser Sintering (SLS), Material Jetting

    3) By Material Type: Resins, Biocompatible Materials, Thermoplastics, Wax

    4) By Application Area: Orthodontics, Prosthodontics, Implantology, Maxillofacial Surgery, Custom Dental Devices

    5) By End-User: Dental Laboratories, Dental Clinics, Educational Institutions, Research Organizations

    Subsegments:

    1) By Desktop 3D Printers: Resin-Based Desktop Printers, Fused Deposition Modeling (FDM) Desktop Printers, Multi-Material Desktop Printers

    2) By Industrial 3D Printers: Selective Laser Sintering (SLS) Industrial Printers, Multi-Jet Fusion (MJF) Printers, Binder Jetting Printers, Polyjet Printers

    3) By Dental Specific 3D Printers: Crown And Bridge Printers, Denture Printers, Orthodontic Appliance Printers, Surgical Guide Printers

    What Future Market Trends Are Projected For The Dental 3D Printing Devices Industry?

    Top-tier businesses engaged in the dental 3D printing devices sector are concentrating on evolving advanced tech such as 3D-printed dentures to augment precision in treatment, cut down on processing times, and boost personalized treatment for patients. 3D-printed dentures are digitally drafted and created using 3D printing technology, making it possible for detailed, adaptively customizable and efficient replacement of lost teeth. To illustrate, the US-based computer manufacturing company, 3D Systems Corporation, released the dental industry’s inaugural multi-material, jetted, one-piece dentures in February 2024. This advanced technology combines unique materials for both teeth and gums into one piece, offering exceptional durability, resistance to breakage, and realistic aesthetics, drastically trimming down on production time and labour effort for dental laboratories. This breakthrough delivers speedier, more pleasant, and enduring dentures for patients thereby improving both the clinical results and patient satisfaction.

    Who Are The Primary Players Operating Across The Global Dental 3D Printing Devices Market?

    Major companies operating in the dental 3d printing devices market are Renishaw, Stratasys Ltd., 3D Systems Corporation, Roland DG Corporation, Formlabs Inc., Materialise NV, Desktop Metal Inc., Carbon Inc., EnvisionTEC GmbH, SprintRay Inc., Prodways Group SA, UnionTech, Structo Pte. Ltd., Zortrax S.A., Kulzer GmbH, BEGO GmbH & Co. KG., Sisma S.p.A., Asiga Pty Ltd., Rapid Shape GmbH, Raise3D Technologies Inc.

    Get The Full Report Here:

    https://www.thebusinessresearchcompany.com/report/dental-3d-printing-devices-global-market-report

    Which Region Offers The Most Growth Potential For The Dental 3D Printing Devices Market Through 2029?

    North America was the largest region in the dental 3D printing devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the dental 3d printing devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Request For A Customized Report:

    https://www.thebusinessresearchcompany.com/customise?id=25735&type=smp

    About The Business Research Company:

    With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 7882 955267 & +91 8897263534

    Europe +44 7882 955267

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Key Market Drivers, Trends, and Forecast for the Global Continence Care Industry

    Key Market Drivers, Trends, and Forecast for the Global Continence Care Industry

    Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

    Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

    What Is the Current and Projected Market Size of the Continence Care Industry?

    The market size for continence care has seen robust expansion in the past years. It’s expected to increase from $15.13 billion in 2024 to $16.15 billion in 2025, posting a compound annual growth rate (CAGR) of 6.7%. The growth during the historic period could be attributed to factors such as a burgeoning elderly population, elevated consciousness about personal hygiene, a rising count of chronic diseases, decreased mobility among senior citizens, and a surge in institutional care admissions.

    In the coming years, the size of the continence care market is predicted to witness substantial progress, with growth escalating to $20.78 billion in 2029 at a compound annual growth rate (CAGR) of 6.5%. The projected growth during this period can be credited to the rising need for home healthcare, the burgeoning of e-commerce platforms, an increase in healthcare spending, better reimbursement policies, and a heightened rate of urologic disorders. The period also earmarks relevant trends such as advancements in absorbent material technologies, breakthroughs in smart continence devices, the emergence of biodegradable products, the commencement of research and development in hypoallergenic materials, and the incorporation of wearable sensors.

    Download The Free Sample Report Here:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=25728&type=smp

    #Which Factors Are Currently Driving The Growth Of The Continence Care Market?

    The surge in instances of urologic disorders is anticipated to spearhead the expansion of the continence care market. Urologic disorders encompass a variety of conditions impacting the urinary tract system, including the kidneys, bladder, and urethra. An uptick in these disorders has largely been ascribed to an aging populace, given the vulnerability of older individuals to urinary tract dysfunction as a result of diminishing muscle tone and other age-related physical alterations. Continence care contributes to symptom management and comfort enhancement for individuals afflicted with urologic conditions. This is achieved by offering vital products that enable urinary control, promote hygiene, and enhance the overall quality of life, particularly for those grappling with chronic bladder problems or age-related urinary dysfunction. For instance, in November 2024, the American Urological Association, a US-based professional group, reported that over 33 million Americans suffered symptoms of overactive bladder, while an estimated 1 to 4 million men and 3 to 8 million women struggled with interstitial cystitis or bladder pain syndrome. As a result, the rising prevalence of urologic disorders is fueling the expansion of the continence care market.

    How Is The Global Continence Care Market Structured In Terms Of Segments?

    The continence care market covered in this report is segmented –

    1) By Product: Urinary Catheter, Non-Implanting Electric Stimulation Devices, Protective Garments, Urine Bag, Bowel Management Products, Other Products

    2) By Material Type: Cotton, Polymer, Nonwoven Fabrics, Foam

    3) By Application: Diabetes, Strokes, Benign Prostatic Hyperplasia, Alzheimer, Cerebral Palsy, Parkinson, Prostate Cancer, Spinal Cord Injury, Bladder Cancer, Other Applications

    4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Stores, Medical Supply Stores

    5) By End User: Hospitals, Home Care Settings, Nursing Homes, Clinics

    Subsegments:

    1) By Urinary Catheter: Intermittent Catheters, Indwelling (Foley) Catheters, External (Condom) Catheters, Suprapubic Catheters, Catheter Maintenance Products

    2) By Non-Implanting Electric Stimulation Devices: Pelvic Floor Stimulators, Transcutaneous Electrical Nerve Stimulation (TENS) Devices For Bladder Control, External Tibial Nerve Stimulation Devices

    3) By Protective Garments: Adult Diapers, Protective Underwear, Pads And Liners, Male Guards, Belted Shields

    4) By Urine Bag: Leg Urine Bags, Bedside Urine Bags, Pediatric Urine Bags, Night Drainage Bags, Urine Bag Accessories

    5) By Bowel Management Products: Rectal Catheters, Stool Collection Bags, Irrigation Systems, Anal Plugs, Bowel Stimulation Devices

    6) By Other Products: Absorbent Sheets, Skin Care Products For Incontinence, Odor Control Products, Deodorizing Tablets

    What Trends Are Currently Influencing Growth In The Continence Care Market?

    Leading companies in the continence care market are concentrating efforts on developing ground-breaking solutions such as digital health technologies to encourage real-time urinary tracking, hydration regulation, and tailored continence care. In essence, digital health solutions integrate digital applications like mobile software, apps, and internet-connected devices to enhance healthcare delivery, support health management, uplift patient results, and facilitate real-time tracking, personalized health assessments, distant monitoring, and bettered patient-healthcare provider communication. For example, Convatec Group Plc, a UK medical products and technologies establishment, introduced the me+ Companion app in August 2024, as a digital health tool to assist intermittently catheterized patients and healthcare professionals by offering real-time urinary tracking, hydration target establishment, leak recordation, and generation of tailored summary reports for improved management of continence care. Through this application, users can conveniently log their levels of fluid consumption and urine output from their mobile gadgets, enabling them to acquire a comprehensive understanding of their condition and make informed decisions. This application further reinforces communication between patients and their care teams, letting users share printable and downloadable reports.

    Who Are The Main Participants Shaping The Continence Care Market Landscape?

    Major companies operating in the continence care market are Cardinal Health Inc., 3M Healthcare, Medtronic plc, Kimberly-Clark Corporation, Unicharm Corporation, Coloplast A/S, Paul Hartmann AG, Convatec Group PLC, Ontex International N.V., Drylock Technologies, First Quality Enterprises Inc., Hollister Incorporated, ABENA A/S, Lohmann & Rauscher GmbH & Co. KG, B. Braun Melsungen AG, Principle Business Enterprises Inc., Premiere Care Industries Inc., Santex S.p.A., Pioneer Hygiene Industries, TZMO SA.

    Get The Full Report Here:

    https://www.thebusinessresearchcompany.com/report/continence-care-global-market-report

    Which Region Currently Holds The Largest Share In The Continence Care Market?

    North America was the largest region in the continence care market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the continence care market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Request For A Customized Report:

    https://www.thebusinessresearchcompany.com/customise?id=25728&type=smp

    About The Business Research Company:

    With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 7882 955267 & +91 8897263534

    Europe +44 7882 955267

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model